U.S. markets close in 18 minutes
  • S&P 500

    4,188.65
    +21.06 (+0.51%)
     
  • Dow 30

    34,466.88
    +236.54 (+0.69%)
     
  • Nasdaq

    13,577.35
    -5.07 (-0.04%)
     
  • Russell 2000

    2,220.38
    -20.99 (-0.94%)
     
  • Crude Oil

    64.79
    -0.84 (-1.28%)
     
  • Gold

    1,814.50
    +30.20 (+1.69%)
     
  • Silver

    27.43
    +0.91 (+3.44%)
     
  • EUR/USD

    1.2066
    +0.0057 (+0.47%)
     
  • 10-Yr Bond

    1.5610
    -0.0230 (-1.45%)
     
  • GBP/USD

    1.3894
    -0.0014 (-0.10%)
     
  • USD/JPY

    109.0300
    -0.1590 (-0.15%)
     
  • BTC-USD

    55,866.82
    -1,353.87 (-2.37%)
     
  • CMC Crypto 200

    1,450.99
    -20.43 (-1.39%)
     
  • FTSE 100

    7,076.17
    +36.87 (+0.52%)
     
  • Nikkei 225

    29,331.37
    +518.77 (+1.80%)
     

Eltek Reports Full Year and Fourth Quarter 2020 Financial Results

  • Oops!
    Something went wrong.
    Please try again later.
·12 min read
  • Oops!
    Something went wrong.
    Please try again later.

- Revenues of $36.7 million in 2020 compared to $34.8 million in 2019 - 5.5% growth in revenues YoY.

- Net profit of $2.6 million in 2020 compared to a net profit of $1.8 million in 2019, growth of 44.4% YoY.

- Revenues of $9.5 million in the fourth quarter of 2020 compared to $8.6 million in the fourth quarter of 2019, a 10.5% increase.

- Net profit of $766,000 in the fourth quarter of 2020 compared to net profit of $370,000 in the fourth quarter of 2019, a 107% increase.

- Achieved gross margins above 21% for the year.

- Achieved $4.6M EBITDA in the year, or 12.5% of total sales.

- Achieved cash flow provided by operating activities of $3.3 million for the year.

- Equity to total balance sheet was 43.4% at the end of 2020 compared to 27.5% at the end of 2019.

PETACH-TIKVA, Israel, March 25, 2021 /PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced today its financial results for the full year and fourth quarter ended December 31, 2020.

Eltek Logo
Eltek Logo

Mr. Eli Yaffe, Chief Executive Officer, commented: "We are pleased with the growth in our revenues and profitability in the fourth quarter and the significant change in our full year results. The improved results reflect the growth in our revenues and the continued improved operating efficiencies."

Eltek has managed successfully through the COVID pandemic in 2020 because of the following actions:

  • Eltek's balance market sectors strategy enabled Eltek to mitigate the downturn in the commercial aerospace market through its involvement in the defense market and the medical devices market.

  • Eltek managed carefully its cash during the pandemic period by obtaining a reduced rate long term loan guaranteed by the government and by raising $5.7 million in a rights offering.

  • Eltek increased investments during 2020 capitalizing on the reduced prices of capital equipment due to Covid.

In addition, we were able to emphasis the following:

  • Eltek used its strong cash flow during 2020 in order to pay back part of its short-term loans. As a result, the ratio of Equity/Total Balance sheet increased to 43.4% at the end of 2020 compared to 27.5% at the end of 2019.

  • Eltek accelerated its R&D plans and was awarded a grant from the Israel Investment Authority and approval for participation in a special R&D program funded by the Israel Innovation Authority.

"The outbreak and spread of the Coronavirus has created new operational and business challenges, including a shortage of certain raw material that we are dealing with. The Covid pandemic forced Eltek to start a new expense reduction plan at the end of 2020 that will reduce further the breakeven point of the company." concluded Mr. Yaffe.

Highlights of the Full Year of 2020 compared to the Full Year of 2019

  • Revenues for the full year of 2020 amounted to $36.7 million compared to revenues of $34.8 million in 2019, an increase of 5.5% YoY.

  • Gross profit increased by 28.3% to $7.7 million (21.0% of revenues) in 2020 from gross profit of $6.0 million (17.3% of revenues) in 2019.

  • Operating profit was $3.0 million in 2020 compared to an operating profit of $1.4 million in 2019, an increase of 114.3% YoY.

  • Net profit was $2.6 million, or $0.58 per fully diluted share in 2020, compared to a net profit of $1.8 million, or $0.48 per fully diluted share in 2019. Net profit increased 44.4% YoY.

  • EBITDA was $4.6 million in 2020 compared to EBITDA of $3.8 million in 2019, an increase of 21.1% YoY.

  • Net cash provided by operating activities amounted to $3.3 million in 2020 compared to $2.6 million in 2019.

  • Cash and cash equivalents as of December 31, 2020 were $4.7 million compared to $1.6 million as of December 31, 2019.

Highlights of the Fourth Quarter of 2020 compared to the Fourth Quarter of 2019

  • Revenues for the fourth quarter of 2020 were $9.5 million compared to revenues of $8.6 million in the fourth quarter of 2019, an increase of 10.5% YoY.

  • Gross profit increased by 46.7% from gross profit of $1.5 million (17.0% of revenues) in the fourth quarter of 2019 to $2.2 million (23.2% of revenues) in the fourth quarter of 2020.

  • Operating profit was $973,000 in the fourth quarter of 2020 compared to an operating profit of $379,000 in the fourth quarter of 2019, an increase of 156.7% YoY.

  • Net profit was $766,000 or $0.16 per fully diluted share in the fourth quarter of 2020 compared to a net profit of $370,000 or $0.08 per fully diluted share in the fourth quarter of 2019. Fourth quarter net profit increased 107.0% YoY.

  • EBITDA was $1.4 million in the fourth quarter of 2020 compared to EBITDA of $817,000 in the fourth quarter of 2019, an increase of 71.4% YoY.

  • Short term credit and loans were down from 24.5% of the total balance sheet at the end of 2019 to 1.9% at the end of 2020.

Use of Non-GAAP Financial Information

The Company reports financial results in accordance with U.S. GAAP and herein provides some non-GAAP measures, including EBITDA. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. These non-GAAP measures are intended to supplement the Company's presentation of its financial results that are prepared in accordance with GAAP. The Company uses the non-GAAP measures presented to evaluate and manage the Company's operations internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation between the company's results on a GAAP and non-GAAP basis is provided in a table below.

Conference Call

Eltek will conduct a conference call to discuss the results today, Thursday, March 25, 2021, at 8:30 a.m. Eastern Time. The call will feature remarks by Eli Yaffe, Chief Executive Officer and Alon Mualem, Chief Financial Officer.

To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:

United States: 1-888-668-9141
Israel: 03-9180691
International: +972-3-9180691

At:

8:30 a.m. Eastern Time
5:30 a.m. Pacific Time
14:30 p.m. Israel Time

A replay of the call will be available through the Investor Info section on Eltek's corporate website at http://www.nisteceltek.com approximately 24 hours after the conference call is completed and will be archived for 30 days.

About Eltek

Eltek – "Innovation Across the Board", is a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), and is the Israeli leader in this industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high quality PCBs, HDI, multilayered and flex-rigid boards for the high-end market. Eltek is ITAR compliant and has AS-9100 and NADCAP Electronics certifications. Its customers include leading companies in the defense, aerospace and medical industries in Israel, the United States, Europe and Asia.

Eltek was founded in 1970. The Company's headquarters, R&D, production and marketing center are located in Israel. Eltek also operates through its subsidiary in North America and by agents and distributors in Europe, India, South Africa and South America.

For more information, visit Eltek's web site at www.nisteceltek.com

Forward Looking Statement:

Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties including, but not limited to expected results in future quarters, the impact of the Coronavirus on the economy and our operations, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company's Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. The information found on our website is not incorporated by reference into this press release and is included for reference purposes only.

Investor Contact:

Alon Mualem
Chief Financial Officer
alonm@nisteceltek.com
+972-3-9395023

Eltek Ltd.

Consolidated Statements of Operations

(In thousands US$, except per share data)












Three months ended


Twelve months ended




December 31,


December 31,




2020

2019


2020


2019








Revenues


9,501

8,582


36,707


34,794


Costs of revenues


(7,290)

(7,124)


(28,969)


(28,787)


Gross profit


2,211

1,458


7,738


6,007











Selling, general and administrative expenses


(1,236)

(1,063)


(4,704)


(4,604)


R&D expenses, net


(2)

(16)


(2)


(16)











Operating profit


973

379


3,032


1,387











Financial expenses, net


(179)

(32)


(337)


(440)


Other income, net


(6)

48


(16)


923











Profit before income tax


788

395


2,679


1,870


Tax expenses


(22)

(25)


(71)


(77)











Net Profit


766

370


2,608


1,793











Earnings per share









Basic and diluted net profit per ordinary share


0.16

0.08


0.58


0.48


Weighted average number of ordinary shares used to compute









basic net profit per ordinary share (in thousands)


4,841

4,380


4,495


3,734


Weighted average number of ordinary shares used to compute









diluted net profit per ordinary share (in thousands)


4,852

4,380


4,501


3,734


Eltek Ltd.

Consolidated Balance Sheets

(In thousands US$)












December 31,

December 31,








2020

2019














Assets


















Current assets









Cash and cash equivalents


4,735

1,628






Receivables: Trade, net of provision for doubtful accounts


9,062

7,480






Other


700

145






Inventories


3,704

3,735






Prepaid expenses


619

530















Total current assets


18,820

13,518















Long term assets









Restricted deposits


62

-






Severance pay fund


64

60






Operating lease right of use assets


8,948

2,490






Total long term assets


9,074

2,550















Fixed assets, less accumulated depreciation


7,263

6,761















Total Assets


35,157

22,829















Liabilities and Shareholder's equity


















Current liabilities









Short-term credit and current maturities of long-term debts


676

2,120






Short-term credit from related party


-

3,472






Accounts payable: Trade


4,452

4,673






Other


3,831

3,118






Short-term operating lease liabilities


742

1,383















Total current liabilities


9,701

14,766















Long-term liabilities









Long term debt, excluding current maturities


1,495

387






Employee severance benefits


338

268






Deferred tax liabilities


84

45






Long-term operating lease liabilities


8,272

1,094















Total long-term liabilities


10,189

1,794















Equity









Ordinary shares, NIS 3.0 par value authorized 10,000,000 shares, issued and outstanding 5,840,357 and 4,380,268 at December 31, 2020 and December 31, 2019, respectively


5,296

3,964






Additional paid-in capital


22,846

18,583






Cumulative foreign currency translation adjustments


3,153

2,479






Capital reserve


1,084

963






Accumulated deficit


(17,112)

(19,720)






Shareholders' equity


15,267

6,269






Total liabilities and shareholders' equity


35,157

22,829






Eltek Ltd.

Unaudited Non-GAAP EBITDA Reconciliations

(In thousands US$)









Non-GAAP EBITDA Reconciliations


Three months ended


Twelve months ended



December 31,


December 31,



2020

2019


2020


2019



Unaudited


Unaudited






GAAP net Income (loss)


766

370


2,608


1,793

Add back items:
















Financial expenses, net


179

32


337


440

Income tax expense


21

25


71


77

Depreciation and amortization


414

390


1,590


1,508

Non-GAAP EBITDA


1,380

817


4,606


3,818

Eltek Ltd.

Consolidated Statement of Cash flow

(In thousands US$)












Three months ended


Twelve months ended




December 31,


December 31,




2020

2019


2020


2019











Cash flows from operating activities:


















Net Income


766

370


2,608


1,793











Adjustments to reconcile net profit to net









cash flows provided by operating activities:









Depreciation and amortization


415

390


1,592


1,508


Capital (gain) loss on disposal of fixed assets, net


14

-


(2)


-


Stock-based compensation


30

53


121


141


Transaction with controlling shareholder


-

(22)


-


22


Revaluation of long term loans


-

(2)


2


(38)


Increase in deferred tax liabilities


15

45


33


45




474

464


1,746


1,678











Decrease (increase) in operating lease right-of-use assets


79

8


74


(3)


Increase in trade receivables


(2,054)

(565)


(956)


(1,277)


Decrease (increase) in other receivables and prepaid expenses


334

(58)


(556)


598


Decrease in inventories


93

77


290


175


Increase (decrease) in trade payables


(476)

15


(449)


107


Increase (decrease) in other liabilities and accrued expenses


267

(473)


448


(529)


Increase in employees severance benefits, net


20

21


47


36




(1,737)

(975)


(1,102)


(893)











Net cash provided by (used in) operating activities


(497)

(141)


3,252


2,578











Cash flows from investing activities:









Purchase of fixed assets


(279)

(263)


(1,082)


(806)


Restricted deposits


-

-


(58)


-


Net cash used in investing activities


(279)

(263)


(1,140)


(806)











Cash flows from financing activities:









Short- term bank credit, net


328

135


(1,600)


(4,181)


Proceeds from short- term shareholder loan


-

2


-


561


Repayment of short- term shareholder loan


(3,090)

-


(3,661)


-


Issuance of ordinary shares in rights offering, net


5,594

-


5,594


3,298


Repayment of long-term loans from bank


(38)

(216)


(183)


(891)


Proceeds from long-term loans


-

-


1,141


558


Repayment of credit from fixed asset payables


(86)

(188)


(477)


(477)


Net cash provided by (used in) financing activities


2,708

(267)


814


(1,132)











Effect of translation adjustments


152

11


181


(4)











Net increase (decrease) in cash and cash equivalents


2,084

(660)


3,107


636











Cash and cash equivalents at beginning of the period


2,651

2,288


1,628


992











Cash and cash equivalents at period end


4,735

1,628


4,735


1,628


Cision
Cision

View original content:http://www.prnewswire.com/news-releases/eltek-reports-full-year-and-fourth-quarter-2020-financial-results-301255853.html

SOURCE Eltek Ltd.